Find Reports

Select Report Type

Reimbursement Review

Displaying 151 - 175 of 1258

Please scroll or swipe to the right to view the full content.

Brand Name	Generic Name	Files	Therapeutic Area	Recommendation Type	Status	Submission Date	Recommendation Date Sort ascending	Project Number
Beovu	brolucizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Diabetic macular edema	Reimburse with clinical criteria and/or conditions	Complete	Jun 30, 2022	Jan 18, 2023	SR0747-000
Dupixent	dupilumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	atopic dermatitis	Reimburse with clinical criteria and/or conditions	Complete	Jul 15, 2022	Jan 18, 2023	SF0754-000
Dayvigo	lemborexant	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Insomnia	Do not reimburse	Complete	Feb 28, 2022	Jan 10, 2023	SR0716-000
Keytruda	pembrolizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Triple-negative breast cancer	Reimburse with clinical criteria and/or conditions	Complete	Jun 20, 2022	Jan 6, 2023	PC0295-000
Nubeqa	darolutamide	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Metastatic castration-sensitive prostate cancer	Reimburse with clinical criteria and/or conditions	Complete	Jun 16, 2022	Jan 5, 2023	PC0294-000
Kimmtrak	tebentafusp	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	unresectable or metastatic uveal melanoma	Reimburse with clinical criteria and/or conditions	Complete	Apr 21, 2022	Jan 4, 2023	PC0290-000
Radicava	edaravone	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Rétroaction des intervenants sur la recommandations provisoire	Amyotrophic lateral sclerosis	Reimburse with clinical criteria and/or conditions	Complete	Mar 10, 2022	Dec 22, 2022	SR0727-000
Zepzelca	lurbinectedin	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	metastatic small cell lung cancer (SCLC)	Do not reimburse	Complete	Feb 24, 2022	Dec 19, 2022	PC0281-000
Vyepti	eptinezumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Migraine	Reimburse with clinical criteria and/or conditions	Complete	Jun 8, 2022	Dec 15, 2022	SR0743-000
Ozurdex	dexamethasone intravitreal implant	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Diabetic macular edema	Do not reimburse	Complete	Jun 8, 2022	Dec 13, 2022	SR0739-000
Wakix	pitolisant hydrochloride	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Narcolepsy	Do not reimburse	Complete	Dec 8, 2021	Dec 6, 2022	SR0715-000
Keytruda	pembrolizumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	recurrent, or metastatic cervical cancer	Reimburse with clinical criteria and/or conditions	Complete	May 20, 2022	Dec 1, 2022	PC0292-000
Tremfya	guselkumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Psoriatic arthritis	Reimburse with clinical criteria and/or conditions	Complete	May 2, 2022	Nov 17, 2022	SR0733-000
Zeposia	ozanimod	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Ulcerative colitis	Reimburse with clinical criteria and/or conditions	Complete	Jan 5, 2022	Nov 17, 2022	SR0714-000
Tezspire	tezepelumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Asthma	Reimburse with clinical criteria and/or conditions	Complete	Apr 14, 2022	Nov 16, 2022	SR0731-000
Xydalba	dalbavancin	Recommendation and Reasons Clinical and Pharmacoeconomic Combined Report Stakeholder Feedback on Draft Recommendation	Acute bacterial skin and skin structure infections	Reimburse with clinical criteria and/or conditions	Complete	Apr 11, 2022	Nov 16, 2022	SR0728-000
Nucala	mepolizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Severe chronic rhinosinusitis with nasal polyps	Reimburse with clinical criteria and/or conditions	Complete	May 11, 2022	Nov 16, 2022	SR0735-000
Vraylar	cariprazine	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Bipolar Disorder	Do not reimburse	Complete	Jan 28, 2022	Nov 9, 2022	SR0718-000
Palynziq	pegvaliase	Memorandum report to CADTH Response to the Procedural Review Panel’s Memorandum Report on the Procedural R…Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Phenylketonuria	Reimburse with clinical criteria and/or conditions	Complete	Dec 22, 2021	Nov 9, 2022	SR0712-000
Keytruda	pembrolizumab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Melanoma Adjuvant Treatment	Reimburse with clinical criteria and/or conditions	Complete	Apr 26, 2022	Nov 4, 2022	PC0286-000
Livtencity	maribavir	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Post-transplant cytomegalovirus infection	Reimburse with clinical criteria and/or conditions	Complete	Mar 31, 2022	Nov 4, 2022	SR0720-000
Rozlytrek	entrectinib	Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Extracranial solid tumours with NTRK gene fusion	Reimburse with clinical criteria and/or conditions	Complete	Jan 25, 2022	Nov 3, 2022	PC0278-000
Cabometyx	cabozantinib	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Differentiated thyroid carcinoma	Reimburse with clinical criteria and/or conditions	Complete	Apr 27, 2022	Nov 2, 2022	PC0287-000
Jardiance	empagliflozin	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Heart failure	Reimburse with clinical criteria and/or conditions	Complete	Apr 6, 2022	Oct 14, 2022	SR0726-000
Vabysmo	faricimab	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Diabetic Macular Edema	Reimburse with clinical criteria and/or conditions	Complete	Mar 24, 2022	Oct 14, 2022	SR0729-000

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 151 - 175 of 589

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Sub Line	Status	Project Number
Utilization of Opioid Agonist Therapies in Canada	Utilization of Opioid Agonist Therapies in Canada	Aug 15, 2023	Technology Review	Completed	HC0064-000
Lipid Panel Screening for Adults Living With Chronic Conditions	Lipid Panel Screening for Adults Living With Chronic Conditions	Aug 10, 2023	Rapid Review	Completed	RC1497-000
Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytial Virus Outcomes in Infants	Cost-Effectiveness of an RSVpreF Vaccine for Prevention of Respiratory Syncytia…	Aug 8, 2023	Technology Review	Complete	HE0044-000
Somatropin for Turner Syndrome	Somatropin for Turner Syndrome	Aug 4, 2023	Rapid Review	Completed	RC1493-000
Somatropin for Growth Hormone Deficiency	Somatropin for Growth Hormone Deficiency	Aug 4, 2023	Rapid Review	Completed	RC1492-000
At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders	At-Home Polysomnography Versus In-Clinic Polysomnography for Sleep Disorders	Aug 4, 2023	Rapid Review	Completed	RC1495-000
Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation	Emergency Care Follow-Up for Children and Adolescents With Suicide Attempts or Ideation	Aug 1, 2023	Rapid Review	Completed	RC1496-000
Evidence Base for Virtual Primary Care	Evidence Base for Virtual Primary Care	Jul 31, 2023	Technology Review	Complete	HC0062-000
Virtual Care Rapid Scoping	Virtual Care Rapid Scoping: Main Report Virtual Care Rapid Scoping: Supporting Information Virtual Care Rapid Scoping: Summary Figures Evidence Map Virtual Care Rapid Scoping: Report Summary	Jul 31, 2023	Scoping Review	Completed	RE0041-000
Individuals’ Access to Medical Imaging Results via Patient Portals	Individuals’ Access to Medical Imaging Results via Patient Portals	Jul 31, 2023	CMII Service	Completed	CM0004-000
Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities	Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Upper Extremities	Jul 31, 2023	Rapid Review	Completed	RC1491-000
Platelet-Rich Plasma Injections for Lower Back Pain	Platelet-Rich Plasma Injections for Lower Back Pain	Jul 31, 2023	Rapid Review	Completed	RC1485-000
Liraglutide for Pediatric Patients with Type 2 Diabetes	Liraglutide for Pediatric Patients with Type 2 Diabetes	Jul 26, 2023	Summary with Critical Appraisal	Completed	RC1494-000
Nirsevimab (Beyfortus) for Respiratory Syncytial Virus Prevention in Neonates and Infants	Nirsevimab (Beyfortus) for Respiratory Syncytial Virus Prevention in Neonates a…	Jul 26, 2023	Technology Review	Complete	HC0059-000
Perioperative Normothermia Interventions to Prevent Caesarean Section Surgical Site Infection	Perioperative Normothermia Interventions to Prevent Caesarean Section Surgical Site Infection	Jul 25, 2023	Summary of Abstracts	Completed	RB1673-000
Electrostimulation Devices for Wounds	Electrostimulation Devices for Wounds	Jul 17, 2023	Rapid Review	Completed	RC1489-000
Point-of-Care HIV and Syphilis Screening	Point-of-Care HIV and Syphilis Screening	Jul 13, 2023	Rapid Review	Completed	RC1490-000
Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Lower Extremities	Platelet-Rich Plasma Injections for Chronic Tendinopathies in the Lower Extremities	Jul 10, 2023	Rapid Review	Completed	RC1486-000
Riluzole for Amyotrophic Lateral Sclerosis Treatment	Riluzole for Amyotrophic Lateral Sclerosis Treatment	Jul 7, 2023	Rapid Review	Completed	RC1487-000
Treatment of Adult Patients With Immune Thrombocytopenia After Failure of First-Line Therapies	Treatment of Adult Patients With Immune Thrombocytopenia After Failure of First…Project Protocol	Jul 6, 2023	Health Technology Assessment	Completed	HT0035-000
Alternative Therapies to Immunoglobulin for Idiopathic Inflammatory Myopathies	Alternative Therapies to Immunoglobulin for Idiopathic Inflammatory Myopathies	Jun 29, 2023	Rapid Review	Completed	RC1484-000
Antimicrobial or Antiseptic Cleansers for Wounds	Antimicrobial or Antiseptic Cleansers for Wounds	Jun 28, 2023	Rapid Review	Completed	RC1488-000
Deep Brain Stimulation Surgery Programs in Canada	Deep Brain Stimulation Surgery Programs in Canada	Jun 13, 2023	Technology Review	Completed	HC0065-000
Alternative Therapies to Immunoglobulin for Autoimmune Blistering Diseases	Alternative Therapies to Immunoglobulin for Autoimmune Blistering Diseases	May 29, 2023	Summary with Critical Appraisal	Completed	RC1483-000
Chloroprocaine for Spinal or Epidural Anesthesia	Chloroprocaine for Spinal or Epidural Anesthesia	May 19, 2023	Rapid Review	Completed	RC1482-000

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 151 - 175 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Philadelphia negative acute lymphoblastic leukemia	Proposed Scope	Dec 12, 2024	Reimbursement Review	Provisional Funding Algorithm	Open for Stakeholder Input	PH0067-000
Non-small-cell lung cancer	Proposed Scope	Dec 12, 2024	Reimbursement Review	Provisional Funding Algorithm	Open for Stakeholder Input	PH0065-000
vutrisiran	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Dec 12, 2024	Reimbursement Review		Complete	SR0801-000
somapacitan	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Dec 12, 2024	Reimbursement Review		Complete	SR0779-000
roflumilast	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Dec 12, 2024	Reimbursement Review		Complete	SR0771-000
cenobamate	Recommendation and Reasons Clinical, Pharmacoeconomic, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Dec 12, 2024	Reimbursement Review		Complete	SR0770-000
dupilumab	Recommendation and Reasons Clinical and Pharmacoeconomic combined Report Stakeholder feedback on Draft Recommendation	Dec 12, 2024	Reimbursement Review		Complete	SR0774-000
setmelanotide	Recommendation and Reasons Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report Stakeholder Feedback on Draft Recommendation	Dec 12, 2024	Reimbursement Review		Complete	SR0769-000
evolocumab	Recommendation and Reason Clinical and Pharmacoeconomic Combined Report Feedback on Draft Recommendation Patient and Clinician Group Input	Dec 11, 2024	Reimbursement Review		Complete	SR0821-000
durvalumab, olaparib, carboplatin, paclitaxel	Patient and Clinician Group Input	Dec 11, 2024	Reimbursement Review		Suspended	PC0366-001
HR positive, HER2 negative breast cancer	Final Report	Dec 10, 2024	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0053-000
Environmental Scan of Genetic and Genomic Biomarker Testing Assessment Frameworks, Processes, and Inventories in Cancer Care		Dec 9, 2024	Health Technology Review		In Progress	CP0037-000
etrasimod	Recommendation and Reason Patient and Clinician Group Input Clinical and Pharmacoeconomic Combined Report Stakeholder feedback on Draft Recommendation	Dec 9, 2024	Reimbursement Review		Complete	SR0795-000
naloxagol	Proposed Scope	Dec 9, 2024	Reimbursement Review		Active	SX0753-000
burosumab	Recommendation and Reason Patient and Clinician Group input	Dec 9, 2024	Reimbursement Review		Active	SR0818-000
Use of Oral Fluoroquinolones in Canada: Drug Utilization Study Update	Report Protocol Summary Report	Dec 6, 2024	Health Technology Review	Technology Review	Complete	HC0073-000
Mepolizumab	Recommendation and Reasons Responses to the Questions From the Drug Programs Clinical and Pharmacoeconomic Combined Report Patient and Clinician Group Input Feedback on Draft Recommendation	Dec 6, 2024	Reimbursement Review		Complete	SX0839-000
Non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutation	Final Report	Dec 5, 2024	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0054-000
Artificial Intelligence–Assisted Colonoscopy for Detecting Polyps, Adenomas, Precancerous Lesions, and Colorectal Cancer	Artificial Intelligence–Assisted Colonoscopy for Detecting Polyps, Adenomas, Pr…	Dec 5, 2024	Health Technology Review	Rapid Review	Completed	RC1559-000
RapidAI for Stroke Detection	Final Recommendation RapidAI for Stroke Detection: Main Report Supporting Information for RapidAI Review Supporting Information for AI Implementation Review	Dec 5, 2024	Health Technology Review	Optimal Use	Active	OP0556-000
Advanced or metastatic gastric, gastroesophageal junction, or esophageal cancer	Final Report	Dec 3, 2024	Reimbursement Review	Provisional Funding Algorithm	Complete	PH0051-000
Appropriate Use of Antipsychotics in Long-Term Care		Dec 3, 2024	Health Technology Review	Technology Review	Active	HC0095-000
Attention-Deficit/Hyperactivity Disorder Medications for Adults	Attention-Deficit/Hyperactivity Disorder Medications for Adults	Dec 3, 2024	Health Technology Review	Rapid Review	Completed	RC1556-000
Pharmaceutical Reviews Update — Issue 53		Nov 28, 2024	Reimbursement Review	Pharmaceutical Review Update
Esophageal or Gastroesophageal Junction Cancer	Proposed Scope	Nov 28, 2024	Reimbursement Review	Provisional Funding Algorithm	Open for Stakeholder Input	PH0061-000